Proteomic and genomic profiling of pancreatic cancer

Forskningsoutput: TidskriftsbidragÖversiktsartikel

Standard

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - Proteomic and genomic profiling of pancreatic cancer

AU - Ansari, Daniel

AU - Torén, William

AU - Zhou, Qimin

AU - Hu, Dingyuan

AU - Andersson, Roland

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Pancreatic cancer remains the most fatal human tumor type. The aggressive tumor biology coupled with the lack of early detection strategies and effective treatment are major reasons for the poor survival rate. Collaborative research efforts have been devoted to understand pancreatic cancer at the molecular level. Large-scale genomic studies have generated important insights into the genetic drivers of pancreatic cancer. In the post-genomic era, protein sequencing of tumor tissue, cell lines, pancreatic juice, and blood from patients with pancreatic cancer has provided a fundament for the development of new diagnostic and prognostic biomarkers. The integration of mass spectrometry and genomic sequencing strategies may help characterize protein identities and post-translational modifications that relate to a specific mutation. Consequently, proteomic and genomic techniques have become a compulsory requirement in modern medicine and health care. These types of proteogenomic studies may usher in a new era of precision diagnostics and treatment in patients with pancreatic cancer.

AB - Pancreatic cancer remains the most fatal human tumor type. The aggressive tumor biology coupled with the lack of early detection strategies and effective treatment are major reasons for the poor survival rate. Collaborative research efforts have been devoted to understand pancreatic cancer at the molecular level. Large-scale genomic studies have generated important insights into the genetic drivers of pancreatic cancer. In the post-genomic era, protein sequencing of tumor tissue, cell lines, pancreatic juice, and blood from patients with pancreatic cancer has provided a fundament for the development of new diagnostic and prognostic biomarkers. The integration of mass spectrometry and genomic sequencing strategies may help characterize protein identities and post-translational modifications that relate to a specific mutation. Consequently, proteomic and genomic techniques have become a compulsory requirement in modern medicine and health care. These types of proteogenomic studies may usher in a new era of precision diagnostics and treatment in patients with pancreatic cancer.

KW - Biomarkers

KW - Genomics

KW - Pancreatic cancer

KW - Proteogenomics

KW - Proteomics

U2 - 10.1007/s10565-019-09465-9

DO - 10.1007/s10565-019-09465-9

M3 - Review article

JO - Cell Biology and Toxicology

T2 - Cell Biology and Toxicology

JF - Cell Biology and Toxicology

SN - 0742-2091

ER -